<DOC>
	<DOC>NCT02446054</DOC>
	<brief_summary>Evaluation the change of patients' glycosylated hemoglobin (HbA1c) after 12 weeks diet control</brief_summary>
	<brief_title>A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease</brief_title>
	<detailed_description>In this study, we provide the delivery service of Musashino T2DM diet for 12 weeks to patients with T2DM, to evaluate the effect on glycosylated hemoglobin (HbA1c), progression and compliance during study period.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>A baseline of glycosylated hemoglobin(HbA1c) is, 10%≥HbA1c≥7%, during past 1 month The subject is able to understand and comply with protocol requirements, instrument The subject and/or subject's primary caregiver is able to have the telephone interview use computer and internet assess Signed and dated written informed consent Pregnancy, breastfeeding or planning to become pregnant during the study Acute illness or infection requiring treatment within 14 days of study entry Other serious disease (e.g. Heart, lung, brain, liver) within 3 months Presence of malignancies Participate in other clinical trial within 30 days prior to this study Alcohol or drug abuse that would interfere with the ability to meet study requirements (opinion of investigator) Concurrent significant medical condition that would limit ability to participate in the study Consider by the investigator to be unsuitable for study participation, for any reason</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>T2DM, type II diabetes Mellitus, HbA1c</keyword>
</DOC>